X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (134) 134
female (127) 127
oncology (70) 70
index medicus (57) 57
breast cancer (53) 53
adult (50) 50
medicine & public health (49) 49
middle aged (49) 49
obstetrics & gynecology (48) 48
gynecology (40) 40
breast neoplasms - drug therapy (36) 36
aged (32) 32
endocrinology (30) 30
breast neoplasms - pathology (29) 29
obstetrics/perinatology (29) 29
cancer (28) 28
pregnancy (28) 28
immunohistochemistry (23) 23
breast neoplasms - metabolism (22) 22
tamoxifen (20) 20
expression (19) 19
care and treatment (17) 17
analysis (16) 16
treatment outcome (16) 16
tumors (16) 16
antineoplastic agents, hormonal - therapeutic use (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
chemotherapy (15) 15
disease-free survival (15) 15
human genetics (15) 15
male (15) 15
medicine (15) 15
postmenopausal women (15) 15
laparoscopy (14) 14
prognosis (14) 14
prospective studies (14) 14
surgery (14) 14
women (14) 14
carcinoma (13) 13
further section (13) 13
internal medicine (13) 13
therapy (13) 13
cancer research (12) 12
obstetrics and gynecology (12) 12
postmenopause (12) 12
risk factors (12) 12
tumor cells, cultured (12) 12
antineoplastic agents - therapeutic use (11) 11
breast neoplasms - genetics (11) 11
diagnosis (11) 11
germany (11) 11
ultrasonography, prenatal (11) 11
aged, 80 and over (10) 10
anastrozole (10) 10
clinical trials (10) 10
further section · weitere sektionen (10) 10
menopause (10) 10
metastasis (10) 10
neoplasm metastasis (10) 10
randomized-trial (10) 10
reproductive biology (10) 10
retrospective studies (10) 10
animals (9) 9
breast neoplasms - mortality (9) 9
cell line, tumor (9) 9
health aspects (9) 9
ovarian cancer (9) 9
adolescent (8) 8
apoptosis (8) 8
aromatase inhibitors (8) 8
aromatase inhibitors - therapeutic use (8) 8
breast-cancer (8) 8
chemotherapy, adjuvant (8) 8
endocrine therapy (8) 8
identification (8) 8
nitriles - therapeutic use (8) 8
receptors, estrogen - metabolism (8) 8
time factors (8) 8
triazoles - therapeutic use (8) 8
biopsy (7) 7
breast neoplasms - therapy (7) 7
cell division (7) 7
exemestane (7) 7
gene expression regulation, neoplastic (7) 7
goserelin (7) 7
letrozole (7) 7
mutation (7) 7
neoplasm staging (7) 7
pathology (7) 7
research (7) 7
research article (7) 7
reverse transcriptase polymerase chain reaction (7) 7
serpin (7) 7
survival (7) 7
survival rate (7) 7
tamoxifen - therapeutic use (7) 7
universities and colleges (7) 7
biochemistry & molecular biology (6) 6
breast neoplasms - surgery (6) 6
cancer patients (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Geburtshilfe und Frauenheilkunde, ISSN 0016-5751, 12/2008, Volume 68, Issue 12, pp. 1141 - 1144
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 904 - 916
Summary Background Phosphatidylinositol 3-kinase (PI3K) pathway activation is a hallmark of endocrine therapy-resistant, hormone receptor-positive breast... 
Hematology, Oncology and Palliative Medicine | HETEROGENEITY | WOMEN | PALBOCICLIB | THERAPY | EXEMESTANE | ONCOLOGY | MUTATION | RESISTANCE | COMBINATION | AROMATASE INHIBITORS | PI3K INHIBITOR | Estradiol - analogs & derivatives | Humans | Middle Aged | Aminopyridines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Alanine Transaminase - blood | Receptors, Estrogen - analysis | Fulvestrant | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Neoplasm Metastasis | Hyperglycemia - chemically induced | DNA, Neoplasm - blood | DNA Mutational Analysis | Exanthema - chemically induced | Postmenopause | Female | Morpholines - adverse effects | Aminopyridines - administration & dosage | Drug Eruptions - etiology | Double-Blind Method | Morpholines - administration & dosage | Estradiol - administration & dosage | Survival Rate | Signal Transduction - genetics | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Retreatment | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Aspartate Aminotransferases - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Medical colleges | Clinical trials | Product development | Breast cancer | Postmenopausal women | Hormones | Antineoplastic agents | Analysis
Journal Article
The Lancet, ISSN 0140-6736, 2005, Volume 366, Issue 9484, pp. 455 - 462
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2009, Volume 27, Issue 16, pp. 2630 - 2637
Purpose Cross-talk between the estrogen receptor (ER) and the phosphoinositide-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathways is a mechanism... 
INHIBITOR RAD001 EVEROLIMUS | MAMMALIAN TARGET | ADVANCED SOLID TUMORS | ONCOLOGY | TAMOXIFEN | DOUBLE-BLIND | ENDOCRINE THERAPY | AKT | POSTMENOPAUSAL WOMEN | PROGNOSTIC VALUE | MTOR | Cyclin D1 - metabolism | Palpation | Triazoles - administration & dosage | Phosphorylation | Receptors, Estrogen - metabolism | Ribosomal Protein S6 Kinases - metabolism | United States | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Ki-67 Antigen - metabolism | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Nitriles - administration & dosage | Time Factors | Aged, 80 and over | Biomarkers, Tumor - metabolism | Postmenopause | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Everolimus | Aromatase Inhibitors - administration & dosage | Sirolimus - analogs & derivatives | Double-Blind Method | Europe | Treatment Outcome | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Gene Expression Regulation, Enzymologic | Phosphatidylinositol 3-Kinases - genetics | Sirolimus - administration & dosage | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Biopsy | Breast Neoplasms - pathology | Aged | Cell Proliferation - drug effects | Mutation | Index Medicus
Journal Article
Der Gynäkologe, ISSN 0017-5994, 1/2017, Volume 50, Issue 1, pp. 8 - 8
Journal Article
Der Gynakologe, ISSN 0017-5994, 01/2017, Volume 50, Issue 1, p. 8
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00129-016-4000-4 
Journal Article
Journal Article
International Journal of Women's Health, ISSN 1179-1411, 03/2015, Volume 7, pp. 305 - 313
Journal Article
Journal Article
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 3/2018, Volume 144, Issue 3, pp. 579 - 586
Physical activity can impact the immune system in different ways, e.g. by alteration of the humoral and cellular immune response. Physical activity at medium... 
Chemotherapy | Medicine & Public Health | Hematology | Physical activity | Oncology | Cancer Research | Internal Medicine | Breast cancer | Immune system | MECHANISMS | ONCOLOGY | Fc receptors | Care and treatment | Physical fitness | Cancer patients | Weight training | Lymphocytes | Analysis | Cancer
Journal Article
Journal Article
Der Gynäkologe, ISSN 0017-5994, 5/2018, Volume 51, Issue 5, pp. 360 - 361
Journal Article
Der Gynakologe, ISSN 0017-5994, 05/2018, Volume 51, Issue 5, p. 360
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00129-018-4245-1 
Journal Article
Gynakologe, ISSN 0017-5994, 05/2018, Volume 51, Issue 5, pp. 360 - 361
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2012, Volume 134, Issue 3, pp. 1149 - 1159
Journal Article